Dr. Jose Antonio Menajovsky, MD

Dr. Menajovsky practices at St. Mary's Medical Center in West Palm Beach, Florida, part of Tenet Healthcare.

Dr. Menajovsky's NPI, 1720231459, was assigned on October 26, 2008. Dr. Menajovsky graduated from National University of San Marcos in 2004. Dr. Menajovsky holds Florida license ME 109354.

Dr. Menajovsky's primary practice is St. Mary's Medical Center, at 901 45th St, West Palm Beach, FL 33407 in Palm Beach County. The practice phone is (561) 840-6202.

Dr. Menajovsky's primary practice is St. Mary's Medical Center in West Palm Beach, Florida, part of Tenet Healthcare. Dr. Menajovsky is also affiliated with Jupiter Medical Center. The medical group on file is Triple O Medical Services. Dmand AI also links Dr. Menajovsky to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menajovsky practices, 8 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Menajovsky's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Menajovsky is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Menajovsky's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acute skin infection, endocarditis, facial skin infection, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Menajovsky treats.

CMS data shows 2,878 Medicare services from Dr. Menajovsky across 10 procedure codes in 2024, for 666 Medicare patients. Medicare paid $291,241 for them.

CMS counts 666 Medicare patients who saw Dr. Menajovsky in 2024. The largest group is 75 to 84, with 234 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Menajovsky's median patient age at 65, with 47% women.

In 2024, Dr. Menajovsky wrote 2,256 Medicare Part D claims for 321 patients. 62% of them were for generic drugs. CMS names the drug for 2,063 of them, across 45 drugs with 11 or more claims each, at $2,919,808 in total drug cost. In 2023, CMS named 1,625 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Menajovsky for performance year 2024, reported individually. Dr. Menajovsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Menajovsky as offering telehealth.

Dmand AI links 2 papers to Dr. Menajovsky in 2011. Dr. Menajovsky's most frequent co-authors are Sunil Adige, MD, Robert L. Bettiker, MD and Heather E. Clauss, MD.

CMS Open Payments shows 1,560 general payments to Dr. Menajovsky from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Gilead Sciences, Inc. paid the most, $6,954.

Dr. Menajovsky graduated from National University of San Marcos in 2004.

Dr. Menajovsky is in network with 13 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.